CGP 39653

Known as: 3-Heptenoic acid, 2-amino-4-(phosphonomethyl)-, (E)-(+-)-, CGP-39653 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1991-1997
01219911997

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
Because cognitive impairments can occur with occupational Pb exposures, changes in NMDA receptor complex function might be… (More)
Is this relevant?
1997
1997
Potential age differences in N-methyl-D-aspartate (NMDA) receptor binding were evaluated in rat brain using [3H]dizocilpine and… (More)
Is this relevant?
1996
1996
Antisense oligodeoxynucleotides were used to determine whether alterations in the expression of N-methyl-D-aspartate (NMDA… (More)
Is this relevant?
1995
1995
Glutathione, both reduced (GSH) and oxidized (GSSG), was effective in displacing binding of L-[3H]-glutamic acid (L-[3H]Glu) and… (More)
Is this relevant?
1995
1995
L-trans-Pyrrolidine-2,4-dicarboxylate (L-t-PDC) and L-threo-3- hydroxyaspartate (L-t-3OHA), compounds known to interact strongly… (More)
Is this relevant?
1993
1993
D,L-(E)-2-Amino-4-propyl-5-phosphono-3-pentenoic acid (CGP 39653), a new, high-affinity, selective NMDA receptor antagonist… (More)
Is this relevant?
1993
1993
Treatment with a low concentration of Triton X-100 almost tripled the binding of [3H]D,L-(E)-2-amino-4-propyl-5-phosphono-3… (More)
Is this relevant?
1991
1991
CGP 39653 (D,L-(E)-2-amino-4-propyl-5-phosphono-3-pentenoic acid) was initially discovered to inhibit the binding of [3H]L… (More)
Is this relevant?